Empagliflozin, a Sodium Glucose Co-Transporter-2 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function in High-Fat Diet/Streptozotocin-Induced Diabetic Rats

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-019-0964-4

Related search